BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9162475)

  • 41. Tumourigenesis associated with the p53 tumour suppressor gene.
    Chang F; Syrjänen S; Tervahauta A; Syrjänen K
    Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 and tumor suppression.
    Van Dyke T
    N Engl J Med; 2007 Jan; 356(1):79-81. PubMed ID: 17202460
    [No Abstract]   [Full Text] [Related]  

  • 43. Transgenic mice with p53-responsive lacZ: p53 activity varies dramatically during normal development and determines radiation and drug sensitivity in vivo.
    Komarova EA; Chernov MV; Franks R; Wang K; Armin G; Zelnick CR; Chin DM; Bacus SS; Stark GR; Gudkov AV
    EMBO J; 1997 Mar; 16(6):1391-400. PubMed ID: 9135154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Life (and death) in a malignant tumour.
    Kinzler KW; Vogelstein B
    Nature; 1996 Jan; 379(6560):19-20. PubMed ID: 8538735
    [No Abstract]   [Full Text] [Related]  

  • 45. A novel pathological role of p53 in kidney development revealed by gene-environment interactions.
    Fan H; Harrell JR; Dipp S; Saifudeen Z; El-Dahr SS
    Am J Physiol Renal Physiol; 2005 Jan; 288(1):F98-107. PubMed ID: 15383401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA damage, oncogenesis and the p53 tumour-suppressor gene.
    Lee JM; Abrahamson JL; Bernstein A
    Mutat Res; 1994 Jun; 307(2):573-81. PubMed ID: 7514730
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonspecific stimulation of the maternal immune system. II. Effects on gene expression in the fetus.
    Sharova L; Sura P; Smith BJ; Gogal RM; Sharov AA; Ward DL; Holladay SD
    Teratology; 2000 Dec; 62(6):420-8. PubMed ID: 11091364
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploiting the p53 pathway for the diagnosis and therapy of human cancer.
    Lane DP
    Cold Spring Harb Symp Quant Biol; 2005; 70():489-97. PubMed ID: 16869788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. p53 mutation heterogeneity in cancer.
    Soussi T; Lozano G
    Biochem Biophys Res Commun; 2005 Jun; 331(3):834-42. PubMed ID: 15865939
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Post-translational modification of p53 and the integration of stress signals.
    Meek DW
    Pathol Biol (Paris); 1997 Dec; 45(10):804-14. PubMed ID: 9769944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensing cellular stress: another new function for the nucleolus?
    Olson MO
    Sci STKE; 2004 Mar; 2004(224):pe10. PubMed ID: 15026578
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of p53 in cell differentiation and development.
    Almog N; Rotter V
    Biochim Biophys Acta; 1997 Aug; 1333(1):F1-27. PubMed ID: 9294016
    [No Abstract]   [Full Text] [Related]  

  • 53. Regulation of p53 function in normal and malignant cells.
    Tortora V; Bontempo P; Verdicchio M; Armetta I; Abbondanza C; Schiavone EM; Nola E; Puca GA; Molinari AM
    Adv Exp Med Biol; 1999; 472():89-100. PubMed ID: 10736619
    [No Abstract]   [Full Text] [Related]  

  • 54. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
    Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
    Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors.
    Maekawa T; Sano Y; Shinagawa T; Rahman Z; Sakuma T; Nomura S; Licht JD; Ishii S
    Oncogene; 2008 Feb; 27(8):1045-54. PubMed ID: 17700520
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Tumor suppressor gene p53].
    Tokino T
    Nihon Rinsho; 1996 Apr; 54(4):960-4. PubMed ID: 8920657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Regulation of p53-MDM2 pathway by nucleolar stress].
    Kawahara K
    Seikagaku; 2013 Mar; 85(3):152-9. PubMed ID: 23631309
    [No Abstract]   [Full Text] [Related]  

  • 58. Cancer as a complex developmental disorder--nineteenth Cornelius P. Rhoads Memorial Award Lecture.
    Dean M
    Cancer Res; 1998 Dec; 58(24):5633-6. PubMed ID: 9865711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The associated contributions of p53 and the DNA mismatch repair protein Msh6 to spontaneous tumorigenesis.
    Young LC; Keuling AM; Lai R; Nation PN; Tron VA; Andrew SE
    Carcinogenesis; 2007 Oct; 28(10):2131-8. PubMed ID: 17615258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experimental assessment of adaptive possibilities after chronic prenatal exposure to gamma irradiation at various absorbed doses].
    Izmest'eva OS; Zhavoronkov LP; Pavlova LN; Drozd AI; Posadskaia VM; Panferova TA
    Radiats Biol Radioecol; 1998; 38(6):826-32. PubMed ID: 9889777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.